Follow-up study of 11 patients with potentially reversible tardive dyskinesia.
The authors followed the course of 11 patients with potentially reversible tardive dyskinesia while they were taking minimum effective neuroleptic doses. After 10 years, the symptoms of tardive dyskinesia had disappeared in eight patients, were minimal or questionable in one, and had become persistent in two.
D000328:Adult; D000978:Antiparkinson Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004409:Dyskinesia, Drug-Induced / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010808:Physical Examination; D013997:Time Factors
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents